Controlled-release biocompatible ocular drug delivery implant devices and methods

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6331313
SERIAL NO

09426141

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Controlled release devices are disclosed which are biocompatible and can be implanted into the eye. The devices have a core comprising a drug and a polymeric outer layer which is substantially impermeable to the entrance of an environmental fluid and substantially impermeable to the release of the drug during a delivery period, and drug release is effected through an orifice in the outer layer. These devices have an orifice area of less than 10% of the total surface area of the device and can be used to deliver a variety of drugs with varying degrees of solubility and or molecular weight. Methods are also provided for using these drug delivery devices.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ALLERGAN, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Berger, Jr Donald E San Jose, CA 8 779
Hu, Mae W L Los Altos Hills, CA 9 975
Wong, Vernon G Menlo Park, CA 64 5284

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation